SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro
- PMID: 19100719
- DOI: 10.1016/j.bcp.2008.11.025
SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro
Abstract
Existence of virus reservoirs makes the eradication of HIV infection extremely difficult. Current drug therapies neither eliminate these viral reservoirs nor prevent their formation. Consequently, new strategies are needed to target these reservoirs with the aim of decreasing their size. We analysed a series of jatrophane diterpenes isolated from Euphorbia hyberna and we found that one of them, SJ23B, induces the internalization of the HIV-1 receptors CD4, CXCR4 and CCR5 and prevents R5 and X4 viral infection in human primary T cells at the nanomolar range. Moreover, SJ23B is a potent antagonist of HIV-1 latency. Using Jurkat-LAT-GFP cells, a model for HIV-1 latency, we found that prostratin and SJ23B activate HIV-1 gene expression, with SJ23B being at least 10-fold more potent than prostratin. SJ23B did not elicit transforming foci activity in NIH 3T3 cells but is a potent activator of PKCalpha and delta as measured by in vitro kinase assays and by cellular translocation experiments. By using isoform-specific PKC inhibitors we found that cPKCs are critical for SJ23B-induced HIV-1 reactivation. We also showed that both SJ23B-induced IkappaBalpha degradation and NF-kappaB activation were inhibited by the classical PKC inhibitor, Gö6976. Accordingly, SJ23B synergizes with ionomycin to translocate PKCalpha to the plasma membrane and to activate the NF-kappaB pathway. Moreover, SJ23B activates both NF-kappaB and Sp1-dependent transcriptional activities in primary T cells. We have shown that diterpene jatrophanes represent a new member of anti-AIDS agents that could be developed for mitigating HIV reactivation.
Similar articles
-
Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.Biochem Pharmacol. 2008 Mar 15;75(6):1370-80. doi: 10.1016/j.bcp.2007.12.004. Epub 2007 Dec 23. Biochem Pharmacol. 2008. PMID: 18241838
-
Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes.Antivir Ther. 2004 Aug;9(4):545-54. Antivir Ther. 2004. PMID: 15456086
-
4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.Biochem Pharmacol. 2020 Jul;177:113937. doi: 10.1016/j.bcp.2020.113937. Epub 2020 Mar 26. Biochem Pharmacol. 2020. PMID: 32224142
-
Prostratin as a new therapeutic agent targeting HIV viral reservoirs.Drug News Perspect. 2005 Oct;18(8):496-500. doi: 10.1358/dnp.2005.18.8.944543. Drug News Perspect. 2005. PMID: 16391719 Review.
-
Activation of latent HIV-1 expression by protein kinase C agonists. A novel therapeutic approach to eradicate HIV-1 reservoirs.Curr Drug Targets. 2011 Mar 1;12(3):348-56. doi: 10.2174/138945011794815266. Curr Drug Targets. 2011. PMID: 20955147 Review.
Cited by
-
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Retrovirology. 2009 Dec 4;6:111. doi: 10.1186/1742-4690-6-111. Retrovirology. 2009. PMID: 19961595 Free PMC article. Review.
-
Dilazep synergistically reactivates latent HIV-1 in latently infected cells.Mol Biol Rep. 2014 Nov;41(11):7697-704. doi: 10.1007/s11033-014-3662-z. Epub 2014 Aug 5. Mol Biol Rep. 2014. PMID: 25091947
-
Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency.AIDS Res Hum Retroviruses. 2015 Jan;31(1):4-12. doi: 10.1089/AID.2014.0199. AIDS Res Hum Retroviruses. 2015. PMID: 25287643 Free PMC article. Review.
-
Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development.J Gen Virol. 2012 Jun;93(Pt 6):1151-1172. doi: 10.1099/vir.0.041186-0. Epub 2012 Mar 14. J Gen Virol. 2012. PMID: 22422068 Free PMC article.
-
Stelleralides A-C, novel potent anti-HIV daphnane-type diterpenoids from Stellera chamaejasme L.Org Lett. 2011 Jun 3;13(11):2904-7. doi: 10.1021/ol200889s. Epub 2011 May 11. Org Lett. 2011. PMID: 21561135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials